Rosalie E. Ferner

Guy's and St Thomas' NHS Foundation Trust — United Kingdom

Medicine · Health Sciences

51h-index11.6kcitations169works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neurofibromatosis and Schwannoma Cases(141), Meningioma and schwannoma management(75), Vascular Malformations Diagnosis and Treatment(41), Sarcoma Diagnosis and Treatment(25), Neuroblastoma Research and Treatments(22)

Publications163 total

PCR5 Perspectives of Adult Patients and Caregivers on the Management and Challenges Associated With Neurofibromatosis Type 1 and Plexiform Neurofibroma: A Multinational, Qualitative Study
Value in Health·2025
Neurofibromatosis type 1
Elsevier eBooks·2024· 1 cited
List of Contributors
Elsevier eBooks·2024Open Access
NFS-21. DEMOGRAPHIC, CLINICAL AND IMAGING CHARACTERISTICS OF NEWLY DIAGNOSED OPTIC PATHWAY GLIOMAS ASSOCIATED WITH NF1: RESULTS FROM THE INTERNATIONAL MULTICENTER NF1-OPG NATURAL HISTORY STUDY
Neuro-Oncology·2024Open Access
NFS-24. TUMOR VOLUME IN NEWLY DIAGNOSED OPTIC PATHWAY GLIOMAS ASSOCIATED WITH NF1 (NF1-OPG): PRELIMINARY RESULTS FROM THE INTERNATIONAL MULTICENTER NF1-OPG NATURAL HISTORY STUDY
Neuro-Oncology·2024Open Access
Association of sociodemographic and clinical factors with the quality of life of Brazilian individuals with Neurofibromatosis type 1: a cross-sectional study
Anais Brasileiros de Dermatologia·2024· 1 citedOpen Access
Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases
Neuro-Oncology Practice·2024· 7 citedOpen Access
Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL
EClinicalMedicine·2023· 32 citedOpen Access
A basket-platform trial for neurofibromatosis type 1: A potential model for rare cancer predisposition syndromes.
Journal of Clinical Oncology·2023· 1 cited
Supplementary Data from Array-Based Comparative Genomic Hybridization Identifies <i>CDK4</i> and <i>FOXM1</i> Alterations as Independent Predictors of Survival in Malignant Peripheral Nerve Sheath Tumor
2023Open Access
Data from Array-Based Comparative Genomic Hybridization Identifies <i>CDK4</i> and <i>FOXM1</i> Alterations as Independent Predictors of Survival in Malignant Peripheral Nerve Sheath Tumor
2023Open Access
Supplementary Table S1 from High-Resolution DNA Copy Number Profiling of Malignant Peripheral Nerve Sheath Tumors Using Targeted Microarray-Based Comparative Genomic Hybridization
2023Open Access
Supplementary Table S3 from High-Resolution DNA Copy Number Profiling of Malignant Peripheral Nerve Sheath Tumors Using Targeted Microarray-Based Comparative Genomic Hybridization
2023Open Access
Supplementary Table S2 from High-Resolution DNA Copy Number Profiling of Malignant Peripheral Nerve Sheath Tumors Using Targeted Microarray-Based Comparative Genomic Hybridization
2023Open Access
Supplementary Table S1 from High-Resolution DNA Copy Number Profiling of Malignant Peripheral Nerve Sheath Tumors Using Targeted Microarray-Based Comparative Genomic Hybridization
2023Open Access
Supplementary Table S4 from High-Resolution DNA Copy Number Profiling of Malignant Peripheral Nerve Sheath Tumors Using Targeted Microarray-Based Comparative Genomic Hybridization
2023Open Access
Data from High-Resolution DNA Copy Number Profiling of Malignant Peripheral Nerve Sheath Tumors Using Targeted Microarray-Based Comparative Genomic Hybridization
2023Open Access
Supplementary Table S4 from High-Resolution DNA Copy Number Profiling of Malignant Peripheral Nerve Sheath Tumors Using Targeted Microarray-Based Comparative Genomic Hybridization
2023Open Access
Data from Array-Based Comparative Genomic Hybridization Identifies <i>CDK4</i> and <i>FOXM1</i> Alterations as Independent Predictors of Survival in Malignant Peripheral Nerve Sheath Tumor
2023Open Access
Supplementary Table S2 from High-Resolution DNA Copy Number Profiling of Malignant Peripheral Nerve Sheath Tumors Using Targeted Microarray-Based Comparative Genomic Hybridization
2023Open Access
page 1 of 9Next →

Frequent Co-authors

D. Gareth Evans(18), David H. Gutmann(17), Robert Listernick(10), Meena Upadhyaya(9), Eric Legius(8), Michael J. Fisher(7), Susan Huson(6), Robert A. Avery(6), Bruce R. Korf(5), Jaishri O. Blakeley(5), Nicole J. Ullrich(5), David Viskochil(5), Victor Mautner(5), Miriam J. Smith(5), Dorothy Halliday(5), C. Oliver Hanemann(5), Matthias A. Karajannis(5), Vincent M. Riccardi(4), Ignacio Blanco(4), Marco Giovannini(4)